Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 3:32 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1249–1266 of 1,266 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Pre-Screening Clear all

Conditions: Colorectal Cancer
Interventions: sample testing; Other
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 65 Years to 80 Years
Enrollment: 4,482 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2009
U.S. locations: 65
States / cities: Tuscon, Arizona • Oakland, California • Aurora, Colorado + 38 more

Conditions: Age-Related Macular Degeneration
Interventions: Retinal Imaging; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 50 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 8
States / cities: Atlanta, Georgia • Fargo, North Dakota • Erie, Pennsylvania + 5 more

Conditions: Cervical Cancer, Papillomavirus Infection, Uterine Diseases, Uterine Cervical Disease
Interventions: COPAN 552c.80 FLOQSwab; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 30 Years to 65 Years · Female only
Enrollment: 3,367 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Obesity
Interventions: Not listed
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 93 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Breast Cancer
Interventions: Questionnaires to Evaluate Anxiety Related to Genetic Testing; Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older · Female only
Enrollment: 164 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Cardiovascular Health Risk Communication, Cardiovascular (CV) Risk, Cardiovascular Disease Prevention
Interventions: Cardiac CT Scan, Bloodwork; Diagnostic Test
Lead sponsor: Northwell Health; Other
Eligibility: 55 Years to 65 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Diffuse Hemispheric Glioma, H3 G34-Mutant
Interventions: Biospecimen Collection, Dendritic Cell Therapy, Leukapheresis, Magnetic Resonance Imaging, Poly ICLC; Procedure · Biological · Drug
Lead sponsor: Jonsson Comprehensive Cancer Center; Other
Eligibility: 18 Years to 50 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Athletes Heart
Interventions: ECG, bedside cardiac ultrasound; Diagnostic Test
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 22 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Colon Cancer
Interventions: BLI850, polyethylene glycol 3350 based bowel preparation; Drug
Lead sponsor: Braintree Laboratories; Industry
Eligibility: 18 Years and older
Enrollment: 386 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 12
States / cities: Anaheim, California • Orange, California • Indianapolis, Indiana + 9 more

Conditions: BPH (Benign Prostatic Hyperplasia), Lower Urinary Tract Symptoms (LUTS)
Interventions: Zenflow Spring System, Sham Procedure; Device
Lead sponsor: Zenflow, Inc.; Industry
Eligibility: 45 Years and older · Male only
Enrollment: 279 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 7
States / cities: Los Angeles, California • Glenview, Illinois • Las Vegas, Nevada + 3 more

Conditions: Sickle Cell Disease
Interventions: IW-1701, Placebo; Drug
Lead sponsor: Cyclerion Therapeutics; Industry
Eligibility: 16 Years to 70 Years
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 30
States / cities: Orange, California • Washington D.C., District of Columbia • Aventura, Florida + 23 more

Conditions: Asthma, Allergic Rhinitis, Atopic Dermatitis
Interventions: Omalizumab, Placebo; Drug
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years to 55 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2012
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Healthy
Interventions: Lisdexamfetamine Dimesylate, Racemic mixture of dextroamphetamine and lisdexamfetamine; Drug
Lead sponsor: Shire; Industry
Eligibility: 18 Years to 25 Years
Enrollment: 3 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Adolescent Behavior
Interventions: I-ACT with Check Yourself; Behavioral
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 13 Years to 18 Years
Enrollment: 302 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Breast Imaging, Breast Cancer
Interventions: Not listed
Lead sponsor: Koning Corporation; Industry
Eligibility: 40 Years and older · Female only
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Hypertension,Essential, White Coat Hypertension
Interventions: Multifaceted Implementation Strategy, Usual care; Behavioral · Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 1,186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 2
States / cities: New York, New York

Conditions: Glioblastoma, IDH-Wildtype, Progressive Astrocytoma, IDH-Mutant, Grade 4, Progressive Glioblastoma, Progressive Gliosarcoma, Recurrent Astrocytoma, IDH-Mutant, Grade 4, Recurrent Glioblastoma, IDH-Wildtype, Recurrent Gliosarcoma, Resectable Astrocytoma, Resectable Glioblastoma
Interventions: Biospecimen Collection, Bispecific CD80-lgG4Fc-IL-2v Fusion Protein GI-102, Computed Tomography, Echocardiography Test, Magnetic Resonance Imaging, Multigated Acquisition Scan, Pembrolizumab, Surgical Procedure; Procedure · Drug · Biological
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Behavior, Health
Interventions: Outdoor Sun Behavior, Indoor Tanning Behavior; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 49 Years
Enrollment: 3,595 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Search by objective public record fields.

Screening Tests in Detecting Colorectal Cancer

Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)

HPV Self-Sampling in Somali Women (Isbaar Project)

The Sweet PEA Study: Effects of Diet During Pregnancy on Infant Growth and Development.

Evaluating the Effects of Genetic Testing on Patients' Stress Levels

Breast Artery Calcification (BAC) and Female Cardiovascular Disease

A Vaccine (Neoantigen-Targeted ppDC) for the Treatment of H3 G34-mutant Diffuse Hemispheric Glioma

Changing the Pulse of Athletics: Applying a Standardized Cardiac Athletic Screening for NCAA Athletes

BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

Safety and Effectiveness Study of the Zenflow Spring System

A Study of the Effect of IW-1701 (Olinciguat), a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD)

Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)

Compare Subjective Drug Liking & Pharmacokinetics of Vyvanse™ and ADDERALL XR® When Administered as an Oral Solution

I-ACT With Check Yourself

Cone Beam CT for Breast Imaging

Implementing Hypertension Screening Guidelines in Primary Care

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Reducing UV Exposure to Prevent Skin Cancer: Message Development & Testing